Gilead buys experimental HIV vaccines from small Barcelona biotech
Aelix Therapeutics took its vaccines into Phase 2 in combination w/the California drugmaker's toll-like receptor agonist vesatolimod
Aelix Therapeutics took its vaccines into Phase 2 in combination w/the California drugmaker's toll-like receptor agonist vesatolimod
Comments